Evidence map›Paper›PMID 39385275›Full record

ArticleCritical care (London, England)2024

Extracorporeal membrane oxygenation for tuberculosis-related acute respiratory distress syndrome: An international multicentre retrospective cohort study.

Ali Ait Hssain, Matthieu Petit, Clemens Wiest, Laura Simon, Abdulrahman A Al-Fares, Ahmed Hany, Dafna I Garcia-Gomez, Santiago Besa, Saad Nseir, Christophe Guervilly and 15 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Critical care (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Ali Ait HssainMedical Intensive Care Unit, Hamad General Hospital, Department of Medicine, Weill Cornell Medical College Doha, College of Health and Life Science, Hamad Bin Khalifa University, Doha, Qatar.
Matthieu PetitMedical Intensive Care Unit, Ambroise Paré Hospital, APHP, Inserm U1018, CESP, University Versailles Saint Quentin - University Paris Saclay, Guyancourt, France.
Clemens WiestDepartment of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany.
Laura SimonDepartment of Critical Care, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Abdulrahman A Al-FaresDepartment of Anesthesia, Critical Care Medicine, and Pain Medicine, Al-Amiri Center for Advanced Respiratory and Cardiac Failure, Al-Amiri Hospital, Ministry of Health, Kuwait City, Kuwait.
Ahmed HanyIntensive Care Unit-Al-Adan Hospital, Ministry of Health-Kuwait, Kuwait City, Kuwait.
Dafna I Garcia-GomezFundacion Cardiovascular de Colombia, Bucaramanga, Colombia.
Santiago BesaDivision of Surgery, Department of Cardiac Surgery, Pontificia Universidad Católica de Chile, Santiago, Chile.
Saad NseirMédecine Intensive-Réanimation, CHU de Lille et Inserm U1285, Université de Lille, CNRS, UMR 8576 - UGSF, 59000, Lille, France.
Christophe GuervillyCenter for Studies and Research on Health Services and Quality of Life EA3279, Aix-Marseille University, Service de Medecine Intensive et Reanimation, CHU Hopital Nord, Assistance Publique Hôpitaux de Marseille (APHM), Marseille, France.
Wael AlqassemCritical Care Department, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, Saudi Arabia.
Mathieu LesouhaitierInfectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, 2 rue Henri Le Guilloux, UMR 1236, Univ Rennes, INSERM, Etablissement Français du Sang Bretagne, Rennes, France.
Adrian ChelaruINSERM U1137, APHP.Nord, Médecine intensive - réanimation, Hôpital Bichat - Claude Bernard, Université Paris Cité, Paris, France.
Simon Wc SinThe University of Hong Kong, Hong Kong, China.
Roberto Roncon-AlbuquerqueDepartment of Intensive Care Medicine, São João University Hospital, Porto, Portugal.
Marco GianiDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Philipp M LepperDepartment of Pneumology, Allergology and Critical Care Medicine, Department of Emergency Medicine, University Hospital of Saarland and University of Saarland, Homburg, Germany.
Jean-Rémi LavillegrandMedical Intensive Care Unit, Henri Mondor Hospital, Creteil, France.
Sunghoon ParkDepartment of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang 14068, South Korea.
Peter SchellongowskiDepartment of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
Ibrahim Fawzy HassanMedical Intensive Care Unit, Hamad General Hospital, Department of Medicine, Weill Cornell Medical College Doha, College of Health and Life Science, Hamad Bin Khalifa University, Doha, Qatar.
Alain CombesSorbonne Université, GRC 30 RESPIRE, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition, Sorbonne Université, 75013, Paris, France.
Romain SonnevilleINSERM U1137, APHP.Nord, Médecine intensive - réanimation, Hôpital Bichat - Claude Bernard, Université Paris Cité, Paris, France.
Matthieu SchmidtSorbonne Université, GRC 30 RESPIRE, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition, Sorbonne Université, 75013, Paris, France. matthieu.schmidt@aphp.fr.
TB ECMO study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo report the outcomes of patients with severe tuberculosis (TB)-related acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO), including predictors of 90-day mortality and associated complications.

methodsAn international multicenter retrospective study was conducted in 20 ECMO centers across 13 countries between 2002 and 2022.

resultsWe collected demographic data, clinical details, ECMO-related complications, and 90-day survival status for 79 patients (median APACHE II score of 20 [25th to 75th percentile, 16 to 28], median age 39 [28 to 48] years, PaO

conclusionThe use of ECMO for TB-related ARDS appears to be justifiable. Patients with miliary TB have a much better prognosis compared to those with cavitary TB on VV ECMO.

Indexed as

Extracorporeal Membrane OxygenationRespiratory Distress SyndromeAdultCohort StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesTuberculosisAcute respiratory distress syndromeExtracorporeal membrane oxygenationMiliaryOutcomeTuberculosis

Identifiers

PMID39385275
PMCPMC11465915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.